Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer-Reference-Cited by-同舟云学术

Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer

Published:2018-01-20 Issue:1 Volume:4 Page:77-90
ISSN:2352-3727
Container-title:Bladder Cancer
language:
Short-container-title:BLC

Author:

Tamura Shuzo¹²³,Wang Yin²⁴,Veeneman Brendan²⁵⁶,Hovelson Daniel²⁵,Bankhead Armand²⁷,Broses Luke J.²⁸,Lorenzatti Hiles Guadalupe²⁸,Liebert Monica²⁸,Rubin John R.²⁸,Day Kathleen C.²⁸,Hussain Maha²⁴⁸⁹,Neamati Nouri¹²,Tomlins Scott²⁵,Palmbos Philip L.²⁴,Grivas Petros²⁴¹⁰,Day Mark L.²⁸

Affiliation:

1. Department of Medicinal Chemistry, School of Pharmacy, University of Michigan, Ann Arbor, MI, USA

2. Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA

3. Current address: Yokohama City University, Yokohama City, Japan

4. Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA

5. Department of Pathology, University of Michigan, Ann Arbor, MI, USA

6. Current Address: Pfizer, Pearl River, NY, USA

7. Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA

8. Department of Urology, University of Michigan, Ann Arbor, MI, USA

9. Current Address: Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA

10. Current address: University of Washington, Seattle, WA, USA

Publisher

IOS Press

Subject

Urology,Oncology

Reference73 articles.

1. Cancer Statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis;Abdollah;Cancer Epidemiol,2013

3. A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now;Bellmunt;Cancer Treat Rev,2017

4. Precision oncology medicine: The clinical relevance of patient-specific biomarkersused to optimize cancer treatment;Schmidt;J Clin Pharmacol,2016

5. Cell signaling by receptor tyrosine kinases;Schlessinger;Cell,2000

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER3 V104 mutations regulate cell signaling, growth, and drug sensitivity in cancer;Molecular Carcinogenesis;2024-05-15

2. Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder Cancer;Targeted Oncology;2024-04-03

3. TCHH as a Novel Prognostic Biomarker for Patients with Gastric Cancer by Bioinformatics Analysis;Clinical and Experimental Gastroenterology;2024-02

4. THE EFFECT OF IMMUNOLOGICAL BIOMARKERS - NLR, PLR, LMR, PD-L1 ON THE SURVIVAL OF PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER;Themed collection of papers from Foreign International Scientific Conference «Modern research on the way to a new scientific revolution». Part 2. by HNRI «National development» in cooperation with AFP (Puerto Cabezas, Nicaragua). November 2023. – Varadero (Cuba);2024-01-23

5. Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1);British Journal of Cancer;2023-12-15